Re:World-first therapy using donor cells sends autoimmune di...
by throwup238 on Saturday October 05, 2024 @06:36PM
(#41753421)
Only for orphan and ultra orphan diseases where there are so few patients that it’s not economically viable to do full clinical trials.
There is also a breakthrough therapy designation where the clinical evidence is solid enough to release the drug while they finish full trials but that’s only in exceptional cases.
There is also a breakthrough therapy designation where the clinical evidence is solid enough to release the drug while they finish full trials but that’s only in exceptional cases.